Featuring Park Gunhyeong, Choi Youngjun, Ko Sangho, Lee Hyunwoo, and More

Director Jang Jin's new play, "Danfoss Was Right," will premiere on June 12 at Yes24 Stage Hall 3 in Jongno-gu, Seoul.


"Danfoss Was Right" is a classic psychological two-hander that delves into the inner worlds of serial killer John Joe, who has murdered 12 people, and the genius profiler Jonas Borton, who confront each other in seven intense encounters. This production marks Director Jang Jin's return to his roots in psychological drama, and is being staged for the first time.

Rehearsal scene from the play 'Danphos Was Right.' Twist1971

Rehearsal scene from the play 'Danphos Was Right.' Twist1971

View original image

The play is set in the Brooklyn Metropolitan Detention Center in New York. Within a strictly isolated space, seven meetings—each limited to just 30 minutes—bring the fragmented memories of the suspect into collision with the profiler's precise analysis.


Director Jang Jin stated, "This time, I will make the audience laugh only six times," signaling that he will restrain his trademark humor and focus on a meticulous psychological portrayal that penetrates the depths of the characters.


The role of genius profiler Jonas Borton, who dissects the criminal's mind using objective data, will be performed by Park Gunhyeong, Choi Youngjun, and Kang Seungho. The role of John Joe, the serial killer who hides a chilling inner side, will be played by Ko Sangho, Kim Hangyeol, and Lee Hyunwoo.


According to the production company Twist 1971 Performing Arts Studio, "The actors are clashing fiercely every day, elevating the intensity of the work. The taut tension created by just two characters, combined with Director Jang Jin's signature sharp text, will deliver a stage that leaves audiences with powerful chills and a lasting impression."



"Danfoss Was Right" will run from June 12 to August 30.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing